Xiangyang Xue

8PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 08, 2025
Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study.

Lele Ye, Chunhao Long, Binbing Xu

|Mar 02, 2024
Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.

Xufeng Lu, Xiaodong Chen, Chengyin Lin

|Sep 10, 2021
NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation.

Yuanbo Hu, Chenbin Chen, Xinya Tong

|Jul 18, 2020
TCONS_00483150 as a novel diagnostic biomarker of systemic lupus erythematosus.

Gangqiang Guo, Aqiong Chen, Lele Ye

|Feb 07, 2020
Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.

Xin Liu, Kangming Lin, Xielin Huang

|Aug 17, 2017
Prognostic significance of Daxx NCR (Nuclear/Cytoplasmic Ratio) in gastric cancer.

Jian-Feng Xu, Zhi-Guang Zhao, Le-le Ye

Pageof 2

Frequent Collaborators

2 joint publications

Yuanbo Hu

2 joint publications

Xian Shen

2 joint publications

Mingdong Lu

2 joint publications

Gangqiang Guo